DK168530B1 - Antitumor-farmaceutiske præparater, fremgangsmåde til deres fremstilling samt anvendelse af polyaminerivater til fremstilling af sådanne præparater - Google Patents

Antitumor-farmaceutiske præparater, fremgangsmåde til deres fremstilling samt anvendelse af polyaminerivater til fremstilling af sådanne præparater Download PDF

Info

Publication number: DK168530B1
Authority: DK; Denmark
Prior art keywords: cells; compounds; cdm; cell; hydrogen
Prior art date: 1983-12-20

Application number

DK329985A

Other languages

Danish (da)

English (en)

Other versions

DK329985D0 (da

DK329985A (da

Inventor

Adam Kovacs

Original Assignee

Adam Kovacs

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-12-20

Filing date

1985-07-19

Publication date

1994-04-18

1985-07-19 Application filed by Adam Kovacs filed Critical Adam Kovacs

1985-07-19 Publication of DK329985D0 publication Critical patent/DK329985D0/da

1985-07-19 Publication of DK329985A publication Critical patent/DK329985A/da

1994-04-18 Application granted granted Critical

1994-04-18 Publication of DK168530B1 publication Critical patent/DK168530B1/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK329985A 1983-12-20 1985-07-19 Antitumor-farmaceutiske præparater, fremgangsmåde til deres fremstilling samt anvendelse af polyaminerivater til fremstilling af sådanne præparater DK168530B1 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
HU834348A HU200093B (en)	1983-12-20	1983-12-20	Process for production of medical compositions against tumour
HU434883		1983-12-20
PCT/HU1984/000062 WO1985002769A1 (fr)	1983-12-20	1984-12-18	Compositions pharmaceutiques antitumorales et leur procede de preparation
HU8400062		1984-12-18

Publications (3)

Publication Number	Publication Date
DK329985D0 DK329985D0 (da)	1985-07-19
DK329985A DK329985A (da)	1985-07-19
DK168530B1 true DK168530B1 (da)	1994-04-18

Family

ID=10967718

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK329985A DK168530B1 (da)	1983-12-20	1985-07-19	Antitumor-farmaceutiske præparater, fremgangsmåde til deres fremstilling samt anvendelse af polyaminerivater til fremstilling af sådanne præparater

Country Status (23)

Country	Link
US (1)	US5068240A (fr)
EP (1)	EP0165960B1 (fr)
JP (1)	JPS61500729A (fr)
KR (1)	KR850700108A (fr)
AU (1)	AU574754B2 (fr)
BR (1)	BR8407235A (fr)
CA (1)	CA1255231A (fr)
DE (1)	DE3477881D1 (fr)
DK (1)	DK168530B1 (fr)
EG (1)	EG17013A (fr)
ES (1)	ES8604490A1 (fr)
FI (1)	FI853199L (fr)
GR (1)	GR82477B (fr)
HU (1)	HU200093B (fr)
IL (1)	IL73825A0 (fr)
IN (1)	IN160438B (fr)
IT (1)	IT1177485B (fr)
MA (1)	MA20305A1 (fr)
NO (1)	NO853241L (fr)
NZ (1)	NZ210558A (fr)
PT (1)	PT79698B (fr)
WO (1)	WO1985002769A1 (fr)
ZA (1)	ZA849897B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7208528B1 (en)	1997-07-15	2007-04-24	Mediquest Therapeutics, Inc.	Polyamine analogues as therapeutic and diagnostic agents
EP1001927A2 (fr) *	1997-07-15	2000-05-24	Oridigm Corporation	Nouveaux analogues de polyamine utilises comme agents therapeutiques et diagnostiques
US6646149B1 (en)	1997-07-15	2003-11-11	Nicolaas M. J. Vermeulin	Polyamine analogues as therapeutic and diagnostic agents
USRE43327E1 (en)	2001-01-08	2012-04-24	Aminex Therapeutics, Inc.	Hydrophobic polyamine analogs and methods for their use
GB0425556D0 (en) *	2004-11-19	2004-12-22	Glaxo Group Ltd	Novel compounds
HUP0900271A2 (hu) *	2009-04-30	2010-11-29	Adam Kovacs	Levegõszûrõ betét védõmaszkhoz, illetve légkezelõ berendezésekhez széles hatásspektrumú gyógyászati kezelési és prevenciós eljárásokban történõ alkalmazásra
EP3695850B1 (fr) *	2010-12-30	2025-05-21	Samyang Holdings Corporation	Compositions pharmaceutiques comprenant un médicament chargé négativement et un lipide cationique
RU2487122C1 (ru) *	2012-05-24	2013-07-10	Общество с ограниченной ответственностью Научно-производственное объединение "НИИПАВ"	Способ получения алкилимидазолина
HUE052620T2 (hu)	2016-03-25	2021-05-28	Aminex Therapeutics Inc	Biológiailag hozzáférhetõ poliaminok
WO2022072586A1 (fr)	2020-09-30	2022-04-07	Aminex Therapeutics, Inc.	Combinaison de substances médicamenteuses à base d'inhibiteur de transport de polyamine et de dfmo
EP4687865A1 (fr) *	2023-04-07	2026-02-11	Université d'Aix-Marseille	Acides gras polyaminés destinés à être utilisés en tant que potentialisateurs d'activité antibactérienne

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3085940A (en) *	1960-05-09	1963-04-16	American Cyanamid Co	Nu, nu'-methylene-bis-amides for the suppression of tumors
FR1202M (fr) *	1960-05-09	1962-03-26	American Cyanamid Co	Compositions d'amides.

1983
- 1983-12-20 HU HU834348A patent/HU200093B/hu not_active IP Right Cessation
1984
- 1984-12-14 IL IL73825A patent/IL73825A0/xx unknown
- 1984-12-14 NZ NZ210558A patent/NZ210558A/en unknown
- 1984-12-17 GR GR82477A patent/GR82477B/el unknown
- 1984-12-18 DE DE8585900164T patent/DE3477881D1/de not_active Expired
- 1984-12-18 FI FI853199A patent/FI853199L/fi not_active Application Discontinuation
- 1984-12-18 KR KR1019850700171A patent/KR850700108A/ko not_active Ceased
- 1984-12-18 BR BR8407235A patent/BR8407235A/pt unknown
- 1984-12-18 US US07/533,943 patent/US5068240A/en not_active Expired - Fee Related
- 1984-12-18 EP EP85900164A patent/EP0165960B1/fr not_active Expired
- 1984-12-18 WO PCT/HU1984/000062 patent/WO1985002769A1/fr not_active Ceased
- 1984-12-18 PT PT79698A patent/PT79698B/pt not_active IP Right Cessation
- 1984-12-18 AU AU37801/85A patent/AU574754B2/en not_active Ceased
- 1984-12-18 JP JP60500050A patent/JPS61500729A/ja active Pending
- 1984-12-19 CA CA000470495A patent/CA1255231A/fr not_active Expired
- 1984-12-19 ES ES538852A patent/ES8604490A1/es not_active Expired
- 1984-12-19 MA MA20529A patent/MA20305A1/fr unknown
- 1984-12-19 ZA ZA849897A patent/ZA849897B/xx unknown
- 1984-12-20 IT IT24159/84A patent/IT1177485B/it active
- 1984-12-23 EG EG804/84A patent/EG17013A/xx active
- 1984-12-27 IN IN1042/MAS/84A patent/IN160438B/en unknown
1985
- 1985-07-19 DK DK329985A patent/DK168530B1/da not_active IP Right Cessation
- 1985-08-16 NO NO853241A patent/NO853241L/no unknown

Also Published As

Publication number	Publication date
EG17013A (en)	1993-07-30
IN160438B (fr)	1987-07-11
FI853199A7 (fi)	1985-08-20
FI853199A0 (fi)	1985-08-20
AU3780185A (en)	1985-07-12
DE3477881D1 (en)	1989-06-01
KR850700108A (ko)	1985-10-25
HUT39602A (en)	1986-10-29
DK329985D0 (da)	1985-07-19
ES538852A0 (es)	1986-02-01
NO853241L (no)	1985-08-16
GR82477B (en)	1985-04-11
CA1255231A (fr)	1989-06-06
DK329985A (da)	1985-07-19
EP0165960B1 (fr)	1989-04-26
IT8424159A0 (it)	1984-12-20
ES8604490A1 (es)	1986-02-01
AU574754B2 (en)	1988-07-14
PT79698A (en)	1985-01-01
JPS61500729A (ja)	1986-04-17
US5068240A (en)	1991-11-26
MA20305A1 (fr)	1985-07-01
HU200093B (en)	1990-04-28
EP0165960A1 (fr)	1986-01-02
BR8407235A (pt)	1985-11-26
NZ210558A (en)	1988-04-29
PT79698B (en)	1987-01-15
ZA849897B (en)	1985-08-28
FI853199L (fi)	1985-08-20
IL73825A0 (en)	1985-03-31
IT1177485B (it)	1987-08-26
WO1985002769A1 (fr)	1985-07-04

Similar Documents

Publication	Publication Date	Title
DiPaolo et al.	1969	Quantitative studies of in vitro transformation by chemical carcinogens
DK168530B1 (da)	1994-04-18	Antitumor-farmaceutiske præparater, fremgangsmåde til deres fremstilling samt anvendelse af polyaminerivater til fremstilling af sådanne præparater
Carchman et al.	1976	The inhibition of DNA synthesis by cannabinoids
DE69412251T2 (de)	1999-01-07	Aromatische nitro verbindungen und deren metabolite verwendbar als anti-virus-und anti-tumormittel
EP0196415B1 (fr)	1991-10-23	Trichostatines A et C comme agents anti-tumeurs
US5004735A (en)	1991-04-02	Pharmaceutical compositions for the inhibition of tumor metastasis
Schmidt et al.	1988	Antiproliferative effect of verapamil alone on brain tumor cells in vitro
Balzarini et al.	1990	Anti‐retrovirus activity of 9‐(2‐phosphonylmethoxyethyl) adenine (PMEA) in vivo increases when it is less frequently administered
Callomon	1943	New derivatives of diaminodiphenylsulfone, their therapeutic effect in experimental tuberculosis of guinea pigs
CN109232718A (zh)	2019-01-18	一种合成肽sp2及其应用
JPH07500581A (ja)	1995-01-19	６−〔Ｘ−（２−ヒドロキシエチル）アミノアルキル〕−５，１１−ジオキソ−５，６−ジヒドロ−１１Ｈ−インデノ〔１，２−ｃ〕イソキノリン誘導体、それらの製造方法およびそれらの使用
Yoshida et al.	1982	Sensitivity to 1‐(4‐amino‐2‐methyl‐5‐pyrimidinyl) methyl‐3‐(2‐chloroethyl)‐3‐nitrosourea hydrochloride (ACNU) of glioma cells in vivo and in vitro
Hill et al.	1971	B16 melanoma in C57BL/6J mice: Kinetics and effects of heterologous serum
De Clercq	1977	Effect of mouse interferon and polyriboinosinic acid· polyribocytidylic acid on L-cell tumor growth in nude mice
Fisher et al.	1976	The effect of a growing tumor and its removal on the cytotoxicity of macrophages from cultured bone marrow cells
Jacobsson et al.	1973	Evidence for a loss of recirculation capacity of T-cells after antigenic stimulation
SE437931B (sv)	1985-03-25	Lekemedelspreparat med antitumorverkan innehallande fosfat av polyhexametylenguanidin med angiven formel
Knight et al.	1994	Seemingly diverse activities of β-alethine
CN116509834B (zh)	2025-05-13	化合物在制备造血干/祖细胞增殖和损伤修复药物中的应用
EP0127389A2 (fr)	1984-12-05	N,N-diéthyl-5-méthyl-2H-1-benzothiopyrano(4,3,2-cd)indazole-2-éthanamine, compositions les contenants et leur utilisation
Nelson	1964	Response of Mice to Reovirus Type 3 in Presence and Absence of Ascites Tumor Cells.
Wierda et al.	1979	Toxicity of platinum complexes on hemopoietic precursor cells.
Clarris et al.	1967	The effects of homologous and heterologous whole serum upon multiplication of recently‐isolated human synovial cells in culture
JPH06501024A (ja)	1994-01-27	皮膚腫瘍形成を予防し、存在する腫瘍の後退の原因になるための医薬組成物と方法
Boggs et al.	1980	Murine recovery from busulfan‐induced hematopoietic toxicity as assessed by three assays for colony‐forming cells

Legal Events

Date	Code	Title	Description
1994-04-18	B1	Patent granted (law 1993)
1996-08-19	PBP	Patent lapsed